3NQ.F NanoCarrier Co. Ltd

Healthcare Biotechnology Frankfurt Exchange
0.3860 EUR
Close of Nov 12, 2026
0.3640 0.9850
Market cap
EUR 32.3M
P/E
-
P/B
1.68x
ROE
-34.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 3NQ.F undervalued?

Graham number

The Graham number of NanoCarrier Co. Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NanoCarrier Co. Ltd fundamental analysis

No fundamental analysis for NanoCarrier Co. Ltd yet.

NanoCarrier Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NanoCarrier Co. Ltd

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano …

Full company profile